Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  New Zealand Stock Exchange  >  AFT Pharmaceuticals Limited    AFT   NZAFTE0001S4

AFT PHARMACEUTICALS LIMITED

(AFT)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization1 242195353544--
Entreprise Value (EV)1 266229394570562555
P/E ratio -19,2x-66,7x30,3x46,4x26,1x17,4x
Yield ----0,83%2,25%
Capitalization / Revenue 3,02x2,29x3,35x4,62x3,87x3,20x
EV / Revenue 3,32x2,70x3,73x4,84x4,00x3,27x
EV / EBITDA -27,1x35,7x31,5x32,7x21,1x13,6x
Price to Book 34,3x38,5x20,5x13,5x9,76x7,12x
Nbr of stocks (in thousands) 96 83597 30897 309104 584--
Reference price (NZD) 2,502,003,635,205,205,20
Last update 05/22/201805/21/201905/19/202011/19/202011/19/202011/19/2020
1 NZD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales1 80,185,1106118140170
EBITDA1 -9,806,4412,517,426,640,9
Operating profit (EBIT)1 -10,16,1211,415,926,137,3
Operating Margin -12,7%7,18%10,8%13,5%18,6%22,0%
Pre-Tax Profit (EBT)1 -12,7-2,2612,912,623,834,8
Net income1 -12,7-2,4312,711,720,831,1
Net margin -15,9%-2,85%12,0%9,89%14,8%18,3%
EPS2 -0,13-0,030,120,110,200,30
Dividend per Share2 ----0,040,12
Last update 05/22/201805/21/201905/19/202011/26/202011/26/202011/19/2020
1 NZD in Million
2 NZD
Estimates
Balance Sheet Analysis
Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt1 23,934,841,126,218,511,1
Net Cash position1 ------
Leverage (Debt / EBITDA) -2,44x5,41x3,28x1,51x0,70x0,27x
Free Cash Flow1 ---3,5015,927,0
ROE (Net Profit / Equities) -94,9%-39,0%114%32,8%38,5%43,6%
Shareholders' equity1 13,46,2211,235,654,171,4
ROA (Net Profit / Asset) ---14,1%22,1%31,6%
Assets1 ---82,794,098,4
Book Value Per Share2 0,070,050,180,380,530,73
Cash Flow per Share2 ---0,100,170,26
Capex1 2,853,476,565,285,406,13
Capex / Sales 3,56%4,07%6,21%4,48%3,85%3,61%
Last update 05/22/201805/21/201905/19/202011/26/202011/26/202011/19/2020
1 NZD in Million
2 NZD
Estimates
Finances - Leverage
Financial data source
© 2021 S&P Global Market Intelligence
Key data
Capitalization (NZD)
543 836 150
Capitalization (USD)
390 098 379
Net sales (NZD)
105 597 000
Net sales (USD)
75 765 848
Number of employees
86
Sales / Employee (NZD)
1 227 872
Sales / Employee (USD)
880 998
Free-Float
28,2%
Free-Float capitalization (NZD)
153 139 490
Free-Float capitalization (USD)
109 848 282
Avg. Exchange 20 sessions (NZD)
115 513
Avg. Exchange 20 sessions (USD)
82 880
Average Daily Capital Traded
0,02%
EPS & Dividend